[Corrections] Correction to Lancet Neurol 2026; 25: 357–67

This notice informs about a correction to a scientific article published in the journal Lancet Neurology in 2026. The original study focused on the integration of plasma biomarkers eMTBR-tau243 and p-tau217 in the diagnosis and stratification of Alzheimer's disease. It was a prospective cohort study conducted by an author team led by Mattsson-Carlgren. The article was originally published in volume 25 of the journal on pages 357 to 367. The correction specifically concerns the appendix of this scientific article. The update and correction of this appendix took place on June 17, 2026.